Hostname: page-component-586b7cd67f-l7hp2 Total loading time: 0 Render date: 2024-12-01T01:15:21.289Z Has data issue: false hasContentIssue false
  • English
  • Français

Pseudomonas aeruginosa Colonization in the Intensive Care Unit: Prevalence, Risk Factors, and Clinical Outcomes

Published online by Cambridge University Press:  01 February 2016

Anthony D. Harris ,
Sarah S. Jackson ,
Gwen Robinson ,
Lisa Pineles ,
Surbhi Leekha ,
Kerri A. Thom ,
Yuan Wang ,
Michelle Doll ,
Melinda M. Pettigrew  and
J. Kristie Johnson
Anthony D. Harris*
Affiliation:
University of Maryland School of Medicine, Baltimore, Maryland
Sarah S. Jackson
Affiliation:
University of Maryland School of Medicine, Baltimore, Maryland
Gwen Robinson
Affiliation:
University of Maryland School of Medicine, Baltimore, Maryland
Lisa Pineles
Affiliation:
University of Maryland School of Medicine, Baltimore, Maryland
Surbhi Leekha
Affiliation:
University of Maryland School of Medicine, Baltimore, Maryland
Kerri A. Thom
Affiliation:
University of Maryland School of Medicine, Baltimore, Maryland
Yuan Wang
Affiliation:
University of Maryland School of Medicine, Baltimore, Maryland
Michelle Doll
Affiliation:
University of Maryland School of Medicine, Baltimore, Maryland
Melinda M. Pettigrew
Affiliation:
Yale School of Public Health, New Haven, Connecticut
J. Kristie Johnson
Affiliation:
University of Maryland School of Medicine, Baltimore, Maryland
*
Address correspondence to Anthony D. Harris, MD, MPH, 10 S. Pine St, MSTF 330, Baltimore, MD 21201 ([email protected]).
Get access Rights & Permissions [Opens in a new window]

Abstract

OBJECTIVE

To determine the prevalence of Pseudomonas aeruginosa colonization on intensive care unit (ICU) admission, risk factors for P. aeruginosa colonization, and the incidence of subsequent clinical culture with P. aeruginosa among those colonized and not colonized.

METHODS

We conducted a cohort study of patients admitted to a medical or surgical intensive care unit of a tertiary care hospital. Patients had admission perirectal surveillance cultures performed. Risk factors analyzed included comorbidities at admission, age, sex, antibiotics received during current hospitalization before ICU admission, and type of ICU.

RESULTS

Of 1,840 patients, 213 (11.6%) were colonized with P. aeruginosa on ICU admission. Significant risk factors in the multivariable analysis for colonization were age (odds ratio, 1.02 [95% CI, 1.01–1.03]), anemia (1.90 [1.05–3.42]), and neurologic disorder (1.80 [1.27–2.54]). Of the 213 patients colonized with P. aeruginosa on admission, 41 (19.2%) had a subsequent clinical culture positive for P. aeruginosa on ICU admission and 60 (28.2%) had a subsequent clinical culture positive for P. aeruginosa in the current hospitalization (ICU period and post-ICU period). Of these 60 patients, 49 (81.7%) had clinical infections. Of the 1,627 patients not colonized on admission, only 68 (4.2%) had a subsequent clinical culture positive for P. aeruginosa in the current hospitalization. Patients colonized with P. aeruginosa were more likely to have a subsequent positive clinical culture than patients not colonized (incidence rate ratio, 6.74 [95% CI, 4.91–9.25]).

CONCLUSIONS

Prediction rules or rapid diagnostic testing will help clinicians more appropriately choose empirical antibiotic therapy for subsequent infections.

Infect Control Hosp Epidemiol 2016;37:544–548

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 37 , Issue 5 , May 2016 , pp. 544 - 548
Copyright
© 2016 by The Society for Healthcare Epidemiology of America. All rights reserved 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1. Magill, SS, Edwards, JR, Bamberg, W, et al. Multistate point-prevalence survey of health care-associated infections. N Engl J Med 2014;370:1198–1208.CrossRefGoogle ScholarPubMed
2. Thuong, M, Arvaniti, K, Ruimy, R, et al. Epidemiology of Pseudomonas aeruginosa and risk factors for carriage acquisition in an intensive care unit. J Hosp Infect 2003;53:274–282.CrossRefGoogle Scholar
3. Nesher, L, Rolston, KV, Shah, DP, et al. Fecal colonization and infection with Pseudomonas aeruginosa in recipients of allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis 2015;17:33–38.CrossRefGoogle ScholarPubMed
4. Green, HP, Johnson, JA, Furuno, JP, et al. Impact of freezing on the future utility of archived surveillance culture specimens. Infect Control Hosp Epidemiol 2007;28:886–888.CrossRefGoogle ScholarPubMed
5. Lautenbach, E, Santana, E, Lee, A, et al. Efficient recovery of fluoroquinolone-susceptible and fluoroquinolone-resistant Escherichia coli strains from frozen samples. Infect Control Hosp Epidemiol 2008;29:367–369.CrossRefGoogle ScholarPubMed
6. Quan, H, Sundararajan, V, Halfon, P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 2005;43:1130–1139.CrossRefGoogle ScholarPubMed
7. Manitoba Centre for Health Policy. Concept: Elixhauser comorbidity index. Manitoba Centre for Health Policy website. http://mchp-appserv.cpe.umanitoba.ca/viewConcept.php?conceptID=1436. Updated 2014. Accessed August 3, 2015.Google Scholar
8. Von Korff, M, Wagner, EH, Saunders, K. A chronic disease score from automated pharmacy data. J Clin Epidemiol 1992;45:197–203.CrossRefGoogle ScholarPubMed
9. Pepin, CS, Thom, KA, Sorkin, JD, et al. Risk factors for central-line–associated bloodstream infections: a focus on comorbid conditions. Infect Control Hosp Epidemiol 2015;36:479–481.CrossRefGoogle ScholarPubMed
10. Harris, AD, Johnson, JK, Thom, KA, et al. Risk factors for development of intestinal colonization with imipenem-resistant Pseudomonas aeruginosa in the intensive care unit setting. Infect Control Hosp Epidemiol 2011;32:719–722.CrossRefGoogle ScholarPubMed
11. Harris, AD, Fleming, B, Bromberg, JS, et al. Surgical site infection after renal transplantation. Infect Control Hosp Epidemiol 2015;36:417–423.CrossRefGoogle ScholarPubMed
12. Centers for Disease Control and Prevention (CDC). CDC/NHSN surveillance definitions for specific types of infections. CDC website. http://www.cdc.gov/nhsn/PDFs/pscManual/17pscNosInfDef_current.pdf. Updated 2015. Accessed January 7, 2016.Google Scholar
13. Zilberberg, MD, Shorr, AF, Micek, ST, Vazquez-Guillamet, C, Kollef, MH. Multi-drug resistance, inappropriate initial antibiotic therapy and mortality in gram-negative severe sepsis and septic shock: a retrospective cohort study. Crit Care 2014;18:596.CrossRefGoogle ScholarPubMed
14. Tumbarello, M, De Pascale, G, Trecarichi, EM, et al. Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients. Intensive Care Med 2013;39:682–692.CrossRefGoogle ScholarPubMed
15. Zaborin, A, Smith, D, Garfield, K, et al. Membership and behavior of ultra-low-diversity pathogen communities present in the gut of humans during prolonged critical illness. MBio 2014;5:e01361–14.CrossRefGoogle ScholarPubMed
16. Modi, SR, Collins, JJ, Relman, DA. Antibiotics and the gut microbiota. J Clin Invest 2014;124:4212–4218.CrossRefGoogle ScholarPubMed
17. Sidler, JA, Frei, R, Tschudin-Sutter, S, et al. Is admission screening for Pseudomonas aeruginosa useful in haematologic patients? A prospective study with 1310 patients. Clin Microbiol Infect 2015;21:572.e1–572.e3.CrossRefGoogle ScholarPubMed
18. Agodi, A, Barchitta, M, Cipresso, R, Giaquinta, L, Romeo, MA, Denaro, C. Pseudomonas aeruginosa carriage, colonization, and infection in ICU patients. Intensive Care Med 2007;33:1155–1161.CrossRefGoogle ScholarPubMed
19. Safdar, N, Maki, DG. The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, enterococcus, gram-negative bacilli, Clostridium difficile, and Candida . Ann Intern Med 2002;136:834–844.CrossRefGoogle ScholarPubMed
20. Ghibu, L, Miftode, E, Teodor, A, Bejan, C, Dorobat, CM. Risk factors for Pseudomonas aeruginosa infections, resistant to carbapenem [in Romanian]. Rev Med Chir Soc Med Nat Iasi 2010;114:1012–1016.Google ScholarPubMed
21. Tuon, FF, Gortz, LW, Rocha, JL. Risk factors for pan-resistant Pseudomonas aeruginosa bacteremia and the adequacy of antibiotic therapy. Braz J Infect Dis 2012;16:351–356.CrossRefGoogle ScholarPubMed
22. Enoch, DA, Kuzhively, J, Sismey, A, Grynik, A, Karas, JA. Pseudomonas aeruginosa bacteraemia in two UK district hospitals. Infect Dis Rep 2013;5:e4.CrossRefGoogle ScholarPubMed
23. Zavascki, AP, Barth, AL, Gaspareto, PB, et al. Risk factors for nosocomial infections due to Pseudomonas aeruginosa producing metallo-beta-lactamase in two tertiary-care teaching hospitals. J Antimicrob Chemother 2006;58:882–885.CrossRefGoogle ScholarPubMed